Abstract:Abstract Background: Alzheimer’s disease (AD) is a leading cause of dementia in the elderly and has become a major health issue. However, a large number of genetic risk factors remain undiscovered. Methods: To identify novel risk genes and better understand the molecular pathway underlying AD, whole-exome sequencing (WES) was performed in 215 early-onset AD (EOAD) patients and 55 unrelated healthy controls of Han Chinese ethnicity. Subsequent direct sequencing was performed in 4962 individuals to validate the selected rare mutations. Computational annotation and in vitro functional studies were performed to evaluate the role of candidate mutations in EOAD and the underlying mechanisms.Results: We identified two rare missense mutations in the phosphodiesterase 11A (PDE11A) gene, resulting in p.Arg202His, and p.Leu756Gln, in individuals with EOAD. Both mutations are located in evolutionarily highly conserved amino acids, are predicted to alter the protein conformation, and classified as pathogenic. Furthermore, we found significantly decreased protein levels of PDE11A in brain samples of AD patients. Expression of PDE11A variants and knockdown experiments with specific short hairpin RNA (shRNA) for PDE11A both resulted in an increase of AD-associated Tau hyperphosphorylation at T181, S404, S202, S416, S214, S396 and AT8 epitopes in vitro. PDE11A variants or PDE11A shRNA also caused increased cAMP levels, protein kinase A (PKA) activation, and cAMP response element-binding protein (CREB) phosphorylation. Additionally, pretreatment with a PKA inhibitor (H89) suppressed PDE11A mutation-induced p-Tau formation.Conclusions: Our results demonstrate that both PDE11A mutations and PDE11A knockdown increase Tau phosphorylation through the cAMP/PKA pathway, suggesting that PDE11A is a novel risk gene for AD. This study provides insight into the involvement of Tau phosphorylation via the cAMP/PKA pathway in EOAD pathogenesis and provides a potential new target for intervention.

Exome sequence analysis of rare frequency variants in Late-Onset Alzheimer Disease

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease

Genome-Wide Meta-Analysis of Late-Onset Alzheimer's Disease Using Rare Variant Imputation in 324,809 Subjects Identifies Novel Rare Variant Locus NCK2: The International Genomics of Alzheimer's Project (IGAP)

In vivo validation of late‐onset Alzheimer's disease genetic risk factors

Association of Rare Variants in Neurodegenerative Genes with Familial Alzheimer's Disease.

Association of Cd33 and Ms4a Cluster Variants with Alzheimer'S Disease in East Asian Populations

Targeted sequencing on neurodegenerative genes identified novel causal and risk variants of familial Alzheimer's disease

Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease

SNP analysis of genes related to cholesterol metabolism and associated with late-onset Alzheimer’s disease

Analysis of Alzheimer's disease associated deleterious non-synonymous single nucleotide polymorphisms and their impacts on protein structure and function by performing in-silico methods

Whole Exome Sequencing Analyses Identified Novel Genes for Alzheimer's Disease and Related Dementia

Genetic Profiles of Familial Late-Onset Alzheimer's Disease in China: the Shanghai FLOAD Study

Identification and Analysis of Alzheimer's Candidate Genes by an Amplitude Deviation Algorithm.

Mutation analysis of the ECE1 gene in late-onset Alzheimer's disease

Whole‐genome sequencing study in Koreans identifies novel loci for Alzheimer's disease

Exome Sequencing Revealed PDE11A as a Novel Candidate Gene for Early-Onset Alzheimer's disease

Genomics and Functional Genomics of Alzheimer’s Disease

A Rare Variant in MLKL Confers Susceptibility to ApoE Ɛ4-Negative Alzheimer's Disease in Hong Kong Chinese Population.

Risk prediction of late-onset Alzheimer’s disease implies an oligogenic architecture

Polygenic Analysis of Late-Onset Alzheimer'S Disease from Mainland China